Breast Cancer Biomarker Analysis- OptraSCAN Inc

Apr 7 01:59 2022 OptraSCAN Inc Print This Article

OptraSCAN® is eliminating the barriers to adopting digital pathology no matter the size of the pathology lab, the lab's throughput or location. Our affordable and easy to implement solutions will maximize your return on investment. OptraSCAN will be a partner to help improve the performance of your pathology services.

Breast Cancer is a very common form of cancer among women that causes an unfavorable effect if left neglected for a long time.

OptraSCAN offers breast cancer biomarker analysis technology. Our Breast Carcinoma Analysis Solution aims at analyzing and interpreting breast carcinoma images to identify and quantify tumors.

Along with identifying tumor clusters,Guest Posting it also focuses on and measures areas of invasive carcinoma and DCIS (Ductal Carcinoma In Situ). Some of the areas that could be quantified include the total tissue area, tumor area as well as invasive cellularity.

This acts as a companion diagnostic tool to help the pathologist in making decisions & above identifications, which otherwise could be greatly challenging and time-consuming.

Features:

  • Evaluates tumor (invasive carcinoma) area and the tissue area
  • Automated evaluation of invasive cellularity in the tumor area
  • Identifies DCIS

Tel: +1-408-524-5300

Contact us at- info@optrascan.com

Read more about- Contact US

Source: Free Guest Posting Articles from ArticlesFactory.com

About Article Author

OptraSCAN Inc
OptraSCAN Inc

OptraSCAN® is eliminating the barriers to adopting digital pathology no matter the size of the pathology lab, the lab's throughput or location. Our affordable and easy-to-implement solutions will maximize your return on investment. OptraSCAN will be a partner to help improve the performance of your pathology services.

View More Articles